Company profile · Biotech & medical
Lumosa Therapeutics
順天醫藥生技股份有限公司 · 6535
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Lumosa Therapeutics is a clinical-stage pharmaceutical company that develops novel therapies and solutions for neurological and oncological diseases with urgent unmet medical needs.[1]
The company engages in scientific licensing and co-development collaboration, building pipelines from early to late-stage assets through its global network and drug development competence.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$0m | -54.9% | -63.0% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$36m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | LUMOSA THERAPEUTICS CO., LTD. |
|---|---|
| Chinese name | 順天醫藥生技股份有限公司 |
| Stock code | 6535 (TPEx) |
| Industry | Biotech & medical |
| Founded | 13 Nov 2000 |
| Listed | 26 Sep 2016 |
| Paid-in capital | NT$1.7bn |
| Chairman | 王素琦 |
| President | 葉聖文 |
| Headquarters | 4F, NO. 3-2, PARK ST., NANGANG DIST., TAIPEI CITY, TAIWAN |
| Website | https://www.lumosa.com.tw |
| Official business description | 新藥開發 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- Lumosa Therapeutics | Lumosa Therapeutics · website · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list